Yohimbine
Early Life Trauma
Charite University, Berlin, GermanySmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Early Life Trauma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Lumateperone University of Texas at Austin | Phase 4 | BB |
HUMAN IMMUNOGLOBULINS National Institute of Mental Health (NIMH) | Phase 3 | B |
Same molecule, other indications
Yohimbine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →